Genetic analysis of the ATG7 gene promoter in sporadic Parkinson's disease

Neuroscience Letters

Volumn 534, Issue 1, 2013, Pages 193-198

  Chen, Dongfeng ^a   Pang, Shuchao ^a   Feng, Xungang ^a   Huang, Wenhui ^a   Hawley, Robert G ^a,b   Yan, Bo ^a,b  

^a JINING MEDICAL UNIVERSITY   (China)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

ATG7; Autophagy; Parkinson's disease; Promoter; Sequence variants

Indexed keywords

ALPHA SYNUCLEIN; AMINO ACID; AUTOPHAGY PROTEIN 7; PROTEIN; UNCLASSIFIED DRUG;

AGED; AMINO ACID SUBSTITUTION; ARTICLE; AUTOPHAGY; CLINICAL ARTICLE; CONTROLLED STUDY; ETHNICITY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; PROMOTER REGION; SPORADIC PARKINSON DISEASE;

AUTOPHAGY; CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; HETEROZYGOTE; HUMANS; MALE; PARKINSON DISEASE; PROMOTER REGIONS, GENETIC; UBIQUITIN-ACTIVATING ENZYMES;

EID: 84873060620     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.12.039     Document Type: Article

References (53)

1. Alvarez-Erviti L., Rodriguez-Oroz M.C., Cooper J.M., Caballero C., Ferrer I., Obeso J.A., Schapira A.H. Chaperone-mediated autophagy markers in Parkinson disease brains. Archives of Neurology 2010, 67:1464-1472.
2. Bar-On P., Crews L., Koob A.O., Mizuno H., Adame A., Spencer B., Masliah E. Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson's disease. Journal of Neurochemistry 2008, 105:1656-1667.
3. Bosco D.A., Fowler D.M., Zhang Q., Nieva J., Powers E.T., Wentworth P., Lerner R.A., Kelly J.W. Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization. Nature Chemical Biology 2006, 2:249-253.
4. Cheung Z.H., Ip N.Y. Autophagy deregulation in neurodegenerative diseases - recent advances and future perspectives. Journal of Neurochemistry 2011, 118:317-325.
5. Coupé B., Ishii Y., Dietrich M.O., Komatsu M., Horvath T.L., Bouret S.G. Loss of autophagy in pro-opiomelanocortin neurons perturbs axon growth and causes metabolic dysregulation. Cell Metabolism 2012, 15:247-255.
6. Crews L., Spencer B., Desplats P., Patrick C., Paulino A., Rockenstein E., Hansen L., Adame A., Galasko D., Masliah E. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. PLoS ONE 2010, 5:e9313.
7. Cuervo A.M., Stefanis L., Fredenburg R., Lansbury P.T., Sulzer D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 2004, 305:1292-1295.
8. Devine M.J., Gwinn K., Singleton A., Hardy J. Parkinson's disease and α-synuclein expression. Movement Disorders 2011, 26:2160-2168.
9. Ezaki J., Matsumoto N., Takeda-Ezaki M., Komatsu M., Takahashi K., Hiraoka Y., Taka H., Fujimura T., Takehana K., Yoshida M., Iwata J., Tanida I., Furuya N., Zheng D.M., Tada N., Tanaka K., Kominami E., Ueno T. Liver autophagy contributes to the maintenance of blood glucose and amino acid levels. Autophagy 2011, 7:727-736.
10. Friedman L.G., Lachenmayer M.L., Wang J., He L., Poulose S.M., Komatsu M., Holstein G.R., Yue Z. Disrupted autophagy leads to dopaminergic axon and dendrite degeneration and promotes presynaptic accumulation of α-synuclein and LRRK2 in the brain. Journal of Neuroscience 2012, 32:7585-7593.
11. Han W., Pan H., Chen Y., Sun J., Wang Y., Li J., Ge W., Feng L., Lin X., Wang X., Wang X., Jin H. EGFR tyrosine kinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells. PLoS ONE 2011, 6:e18691.
12. Harris H., Rubinsztein D.C. Control of autophagy as a therapy for neurodegenerative disease. Nature Reviews Neurology 2012, 8:108-117.
13. Hirsch E.C., Hunot S. Neuroinflammation in Parkinson's disease: a target for neuroprotection. The Lancet Neurology 2009, 8:382-397.
14. Huang X., Chen H., Miller W.C., Mailman R.B., Woodard J.L., Chen P.C., Xiang D., Murrow R.W., Wang Y.Z., Poole C. Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease. Movement Disorders 2007, 22:377-381.
15. Ichimura Y., Kirisako T., Takao T., Satomi Y., Shimonishi Y., Ishihara N., Mizushima N., Tanida I., Kominami E., Ohsumi M., Noda T., Ohsumi Y. A ubiquitin-like system mediates protein lipidation. Nature 2000, 408:488-492.
16. Ichimura Y., Imamura Y., Emoto K., Umeda M., Noda T., Ohsumi Y. In vivo and in vitro reconstitution of Atg8 conjugation essential for autophagy. Journal of Biological Chemistry 2004, 279:40584-40592.
17. Jacquel A., Obba S., Boyer L., Dufies M., Robert G., Gounon P., Lemichez E., Luciano F., Solary E., Auberger P. Autophagy is required for CSF-1-induced macrophagic differentiation and acquisition of phagocytic functions. Blood 2012, 119:4527-4531.
18. Komatsu M., Waguri S., Ueno T., Iwata J., Murata S., Tanida I., Ezaki J., Mizushima N., Ohsumi Y., Uchiyama Y., Kominami E., Tanaka K., Chiba T. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. Journal of Cell Biology 2005, 169:425-434.
19. Komatsu M., Waguri S., Chiba T., Murata S., Iwata J., Tanida I., Ueno T., Koike M., Uchiyama Y., Kominami E., Tanaka K. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006, 441:880-884.
20. Komatsu M., Wang Q.J., Holstein G.R., Friedrich V.L., Iwata J., Kominami E., Chait B.T., Tanaka K., Yue Z. Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:14489-14494.
21. Koob A.O., Ubhi K., Paulsson J.F., Kelly J., Rockenstein E., Mante M., Adame A., Masliah E. Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies. Experimental Neurology 2010, 221:267-274.
22. Lee I.H., Finkel T. Regulation of autophagy by the p300 acetyltransferase. Journal of Biological Chemistry 2009, 284:6322-6328.
23. Lee I.H., Cao L., Mostoslavsky R., Lombard D.B., Liu J., Bruns N.E., Tsokos M., Alt F.W., Finkel T. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:3374-3379.
24. Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
25. Liu J.P., Tang Y., Zhou S., Toh B.H., McLean C., Li H. Cholesterol involvement in the pathogenesis of neurodegenerative diseases. Molecular and Cellular Neurosciences 2010, 43:33-42.
26. Martin I., Dawson V.L., Dawson T.M. Recent advances in the genetics of Parkinson's disease. Annual Review of Genomics and Human Genetics 2011, 12:301-325.
27. Metzger S., Saukko M., Van Che H., Tong L., Puder Y., Riess O., Nguyen H.P. Age at onset in Huntington's disease is modified by the autophagy pathway: implication of the V471A polymorphism in Atg7. Human Genetics 2010, 128:453-459.
28. Mizushima N. Autophagy: process and function. Genes and Development 2007, 21:2861-2873.
29. Mizushima N., Yoshimori T., Ohsumi Y. The role of Atg proteins in autophagosome formation. Annual Review of Cell and Developmental Biology 2011, 27:107-132.
30. Pan T., Kondo S., Le W., Jankovic J. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. Brain 2008, 131:1969-1978.
31. Pang S., Chen D., Zhang A., Qin X., Yan B. Genetic analysis of the LAMP-2 gene promoter in patients with sporadic Parkinson's disease. Neuroscience Letters 2012, 526:63-67.
32. Ravikumar B., Sarkar S., Davies J.E., Futter M., Garcia-Arencibia M., Green-Thompson Z.W., Jimenez-Sanchez M., Korolchuk V.I., Lichtenberg M., Luo S., Massey D.C., Menzies F.M., Moreau K., Narayanan U., Renna M., Siddiqi F.H., Underwood B.R., Winslow A.R., Rubinsztein D.C. Regulation of mammalian autophagy in physiology and pathophysiology. Physiological Reviews 2010, 90:1383-1435.
33. Rochet J.C., Hay B.A., Guo M. Molecular insights into Parkinson's disease. Progress in Molecular Biology and Translational Science 2012, 107:125-188.
34. Sanjuan M.A., Dillon C.P., Tait S.W., Moshiach S., Dorsey F., Connell S., Komatsu M., Tanaka K., Cleveland J.L., Withoff S., Green D.R. Toll-like receptor signaling in macrophages links the autophagy pathway to phagocytosis. Nature 2007, 450:1253-1257.
35. Schapira A.H., Jenner P. Etiology and pathogenesis of Parkinson's disease. Movement Disorders 2011, 26:1049-1055.
36. Shulman J.M., De Jager P.L., Feany M.B. Parkinson's disease: genetics and pathogenesis. Annual Review of Pathology 2011, 6:193-222.
37. Singh R., Kaushik S., Wang Y., Xiang Y., Novak I., Komatsu M., Tanaka K., Cuervo A.M., Czaja M.J. Autophagy regulates lipid metabolism. Nature 2009, 458:1131-1135.
38. Singh R., Xiang Y., Wang Y., Baikati K., Cuervo A.M., Luu Y.K., Tang Y., Pessin J.E., Schwartz G.J., Czaja M.J. Autophagy regulates adipose mass and differentiation in mice. Journal of Clinical Investigation 2009, 119:3329-3339.
39. Tanida I., Mizushima N., Kiyooka M., Ohsumi M., Ueno T., Ohsumi Y., Kominami E. Apg7p/Cvt2p: a novel protein-activating enzyme essential for autophagy. Molecular Biology of the Cell 1999, 10:1367-1379.
40. Tanida I., Tanida-Miyake E., Ueno T., Kominami E. The human homolog of Saccharomyces cerevisiae Apg7p is a Protein-activating enzyme for multiple substrates including human Apg12p, GATE-16, GABARAP, and MAP-LC3. Journal of Biological Chemistry 2001, 276:1701-1706.
41. Tanida I., Tanida-Miyake E., Komatsu M., Ueno T., Kominami E. Human Apg3p/Aut1p homologue is an authentic E2 enzyme for multiple substrates, GATE-16, GABARAP, and MAP-LC3, and facilitates the conjugation of hApg12p to hApg5p. Journal of Biological Chemistry 2002, 277:13739-13744.
42. Tansey M.G., Goldberg M.S. Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiology of Disease 2010, 37:510-518.
43. Vekrellis K., Xilouri M., Emmanouilidou E., Rideout H.J., Stefanis L. Pathological roles of α-synuclein in neurological disorders. The Lancet Neurology 2011, 10:1015-1025.
44. Vogiatzi T., Xilouri M., Vekrellis K., Stefanis L. Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. Journal of Biological Chemistry 2008, 283:23542-23556.
45. Webb J.L., Ravikumar B., Atkins J., Skepper J.N., Rubinsztein D.C. α-Synuclein is degraded by both autophagy and the proteasome. Journal of Biological Chemistry 2003, 278:25009-25013.
46. Wong E., Cuervo A.M. Autophagy gone awry in neurodegenerative diseases. Nature Neuroscience 2010, 13:805-811.
47. Wu G., Wang X., Feng X., Zhang A., Li J., Gu K., Huang J., Pang S., Dong H., Gao H., Yan B. Altered expression of autophagic genes in the peripheral leukocytes of patients with sporadic Parkinson's disease. Brain Research 2011, 1394:105-111.
48. Xilouri M., Stefanis L. Autophagic pathways in Parkinson disease and related disorders. Expert Reviews in Molecular Medicine 2011, 13:e8.
49. Xilouri M., Vogiatzi T., Vekrellis K., Park D., Stefanis L. Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. PLoS ONE 2009, 4:e5515.
50. Yu W.H., Dorado B., Figueroa H.Y., Wang L., Planel E., Cookson M.R., Clark L.N., Duff K.E. Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein. American Journal of Pathology 2009, 175:736-747.
51. Yuan W., Stromhaug P.E., Dunn W.A. Glucose-induced autophagy of peroxisomes in Pichia pastoris requires a unique E1-like protein. Molecular Biology of the Cell 1999, 10:1353-1366.
52. Zhang Y., Goldman S., Baerga R., Zhao Y., Komatsu M., Jin S. Adipose-specific deletion of autophagy-related gene 7 (atg7) in mice reveals a role in adipogenesis. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:19860-19865.
53. Zhu K., Dunner K., McConkey D.J. Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells. Oncogene 2010, 29:451-462.